nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.098	0.125	CbGbCtD
Nisoldipine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0841	0.108	CbGbCtD
Nisoldipine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0652	0.0834	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0652	0.0834	CbGbCtD
Nisoldipine—ABCB1—Betamethasone—ankylosing spondylitis	0.0547	0.07	CbGbCtD
Nisoldipine—ABCB1—Prednisolone—ankylosing spondylitis	0.054	0.0691	CbGbCtD
Nisoldipine—ABCB1—Prednisone—ankylosing spondylitis	0.051	0.0652	CbGbCtD
Nisoldipine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0504	0.0645	CbGbCtD
Nisoldipine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0489	0.0625	CbGbCtD
Nisoldipine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0382	0.0489	CbGbCtD
Nisoldipine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0328	0.0419	CbGbCtD
Nisoldipine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0323	0.0414	CbGbCtD
Nisoldipine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0318	0.0407	CbGbCtD
Nisoldipine—CYP3A4—Prednisone—ankylosing spondylitis	0.0305	0.0391	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—ankylosing spondylitis	0.0256	0.0327	CbGbCtD
Nisoldipine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0191	0.0244	CbGbCtD
Nisoldipine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000646	0.00296	CcSEcCtD
Nisoldipine—Dry skin—Prednisone—ankylosing spondylitis	0.000645	0.00296	CcSEcCtD
Nisoldipine—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00064	0.00293	CcSEcCtD
Nisoldipine—Weight increased—Betamethasone—ankylosing spondylitis	0.000636	0.00291	CcSEcCtD
Nisoldipine—Weight increased—Dexamethasone—ankylosing spondylitis	0.000636	0.00291	CcSEcCtD
Nisoldipine—Weight decreased—Betamethasone—ankylosing spondylitis	0.000632	0.0029	CcSEcCtD
Nisoldipine—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000632	0.0029	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000623	0.00286	CcSEcCtD
Nisoldipine—Muscular weakness—Prednisone—ankylosing spondylitis	0.000621	0.00284	CcSEcCtD
Nisoldipine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000618	0.00283	CcSEcCtD
Nisoldipine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000616	0.00282	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000614	0.00281	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000614	0.00281	CcSEcCtD
Nisoldipine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000611	0.0028	CcSEcCtD
Nisoldipine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00061	0.0028	CcSEcCtD
Nisoldipine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00061	0.0028	CcSEcCtD
Nisoldipine—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000605	0.00277	CcSEcCtD
Nisoldipine—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000605	0.00277	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.0006	0.00275	CcSEcCtD
Nisoldipine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000592	0.00271	CcSEcCtD
Nisoldipine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00056	0.00257	CcSEcCtD
Nisoldipine—Weight increased—Prednisone—ankylosing spondylitis	0.000554	0.00254	CcSEcCtD
Nisoldipine—Ataxia—Methotrexate—ankylosing spondylitis	0.000553	0.00253	CcSEcCtD
Nisoldipine—Weight decreased—Prednisone—ankylosing spondylitis	0.00055	0.00252	CcSEcCtD
Nisoldipine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000543	0.00249	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000541	0.00248	CcSEcCtD
Nisoldipine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000539	0.00247	CcSEcCtD
Nisoldipine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000539	0.00247	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000535	0.00245	CcSEcCtD
Nisoldipine—Angioedema—Prednisolone—ankylosing spondylitis	0.000533	0.00244	CcSEcCtD
Nisoldipine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000532	0.00244	CcSEcCtD
Nisoldipine—Malaise—Prednisolone—ankylosing spondylitis	0.000526	0.00241	CcSEcCtD
Nisoldipine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000525	0.00241	CcSEcCtD
Nisoldipine—Vertigo—Prednisolone—ankylosing spondylitis	0.000524	0.0024	CcSEcCtD
Nisoldipine—Syncope—Prednisolone—ankylosing spondylitis	0.000523	0.0024	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000513	0.00235	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—ankylosing spondylitis	0.000508	0.00233	CcSEcCtD
Nisoldipine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000498	0.00228	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000496	0.00228	CcSEcCtD
Nisoldipine—Alopecia—Betamethasone—ankylosing spondylitis	0.000494	0.00226	CcSEcCtD
Nisoldipine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000494	0.00226	CcSEcCtD
Nisoldipine—Discomfort—Prednisolone—ankylosing spondylitis	0.000491	0.00225	CcSEcCtD
Nisoldipine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00049	0.00225	CcSEcCtD
Nisoldipine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000489	0.00224	CcSEcCtD
Nisoldipine—Malaise—Triamcinolone—ankylosing spondylitis	0.000484	0.00222	CcSEcCtD
Nisoldipine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000483	0.00221	CcSEcCtD
Nisoldipine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000482	0.00221	CcSEcCtD
Nisoldipine—Syncope—Triamcinolone—ankylosing spondylitis	0.000481	0.0022	CcSEcCtD
Nisoldipine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000481	0.0022	CcSEcCtD
Nisoldipine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00048	0.0022	CcSEcCtD
Nisoldipine—Oedema—Prednisolone—ankylosing spondylitis	0.000476	0.00218	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—ankylosing spondylitis	0.000475	0.00218	CcSEcCtD
Nisoldipine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000471	0.00216	CcSEcCtD
Nisoldipine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00047	0.00216	CcSEcCtD
Nisoldipine—Shock—Prednisolone—ankylosing spondylitis	0.000468	0.00215	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000468	0.00215	CcSEcCtD
Nisoldipine—Cough—Triamcinolone—ankylosing spondylitis	0.000468	0.00214	CcSEcCtD
Nisoldipine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000465	0.00213	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00046	0.00211	CcSEcCtD
Nisoldipine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000457	0.00209	CcSEcCtD
Nisoldipine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000456	0.00209	CcSEcCtD
Nisoldipine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000456	0.00209	CcSEcCtD
Nisoldipine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000454	0.00208	CcSEcCtD
Nisoldipine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000451	0.00207	CcSEcCtD
Nisoldipine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000451	0.00207	CcSEcCtD
Nisoldipine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000451	0.00207	CcSEcCtD
Nisoldipine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00045	0.00206	CcSEcCtD
Nisoldipine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000447	0.00205	CcSEcCtD
Nisoldipine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000445	0.00204	CcSEcCtD
Nisoldipine—Angioedema—Betamethasone—ankylosing spondylitis	0.000445	0.00204	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000442	0.00202	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000441	0.00202	CcSEcCtD
Nisoldipine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00044	0.00202	CcSEcCtD
Nisoldipine—Malaise—Dexamethasone—ankylosing spondylitis	0.000439	0.00201	CcSEcCtD
Nisoldipine—Malaise—Betamethasone—ankylosing spondylitis	0.000439	0.00201	CcSEcCtD
Nisoldipine—Oedema—Triamcinolone—ankylosing spondylitis	0.000438	0.00201	CcSEcCtD
Nisoldipine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000437	0.002	CcSEcCtD
Nisoldipine—Vertigo—Betamethasone—ankylosing spondylitis	0.000437	0.002	CcSEcCtD
Nisoldipine—Syncope—Betamethasone—ankylosing spondylitis	0.000436	0.002	CcSEcCtD
Nisoldipine—Syncope—Dexamethasone—ankylosing spondylitis	0.000436	0.002	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—ankylosing spondylitis	0.000434	0.00199	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—ankylosing spondylitis	0.000432	0.00198	CcSEcCtD
Nisoldipine—Shock—Triamcinolone—ankylosing spondylitis	0.000431	0.00197	CcSEcCtD
Nisoldipine—Insomnia—Prednisolone—ankylosing spondylitis	0.00043	0.00197	CcSEcCtD
Nisoldipine—Alopecia—Prednisone—ankylosing spondylitis	0.00043	0.00197	CcSEcCtD
Nisoldipine—Shock—Methylprednisolone—ankylosing spondylitis	0.00043	0.00197	CcSEcCtD
Nisoldipine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000428	0.00196	CcSEcCtD
Nisoldipine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000428	0.00196	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000427	0.00196	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000427	0.00196	CcSEcCtD
Nisoldipine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000427	0.00196	CcSEcCtD
Nisoldipine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000426	0.00195	CcSEcCtD
Nisoldipine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000423	0.00194	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000422	0.00193	CcSEcCtD
Nisoldipine—Myalgia—Betamethasone—ankylosing spondylitis	0.000414	0.0019	CcSEcCtD
Nisoldipine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000414	0.0019	CcSEcCtD
Nisoldipine—Anxiety—Betamethasone—ankylosing spondylitis	0.000413	0.00189	CcSEcCtD
Nisoldipine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000413	0.00189	CcSEcCtD
Nisoldipine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000409	0.00188	CcSEcCtD
Nisoldipine—Discomfort—Betamethasone—ankylosing spondylitis	0.000409	0.00188	CcSEcCtD
Nisoldipine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000408	0.00187	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000404	0.00185	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000399	0.00183	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000398	0.00182	CcSEcCtD
Nisoldipine—Oedema—Betamethasone—ankylosing spondylitis	0.000397	0.00182	CcSEcCtD
Nisoldipine—Oedema—Dexamethasone—ankylosing spondylitis	0.000397	0.00182	CcSEcCtD
Nisoldipine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000396	0.00181	CcSEcCtD
Nisoldipine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000395	0.00181	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000393	0.0018	CcSEcCtD
Nisoldipine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000393	0.0018	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000392	0.0018	CcSEcCtD
Nisoldipine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000392	0.0018	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000392	0.0018	CcSEcCtD
Nisoldipine—Anaemia—Prednisone—ankylosing spondylitis	0.000392	0.00179	CcSEcCtD
Nisoldipine—Shock—Dexamethasone—ankylosing spondylitis	0.000391	0.00179	CcSEcCtD
Nisoldipine—Shock—Betamethasone—ankylosing spondylitis	0.000391	0.00179	CcSEcCtD
Nisoldipine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00039	0.00179	CcSEcCtD
Nisoldipine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000388	0.00178	CcSEcCtD
Nisoldipine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000388	0.00178	CcSEcCtD
Nisoldipine—Angioedema—Prednisone—ankylosing spondylitis	0.000387	0.00177	CcSEcCtD
Nisoldipine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000385	0.00177	CcSEcCtD
Nisoldipine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000384	0.00176	CcSEcCtD
Nisoldipine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000384	0.00176	CcSEcCtD
Nisoldipine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000384	0.00176	CcSEcCtD
Nisoldipine—Malaise—Prednisone—ankylosing spondylitis	0.000382	0.00175	CcSEcCtD
Nisoldipine—Vertigo—Prednisone—ankylosing spondylitis	0.000381	0.00174	CcSEcCtD
Nisoldipine—Syncope—Prednisone—ankylosing spondylitis	0.00038	0.00174	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000379	0.00174	CcSEcCtD
Nisoldipine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000379	0.00173	CcSEcCtD
Nisoldipine—Anorexia—Betamethasone—ankylosing spondylitis	0.000379	0.00173	CcSEcCtD
Nisoldipine—Urticaria—Prednisolone—ankylosing spondylitis	0.000378	0.00173	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000372	0.00171	CcSEcCtD
Nisoldipine—Hypotension—Betamethasone—ankylosing spondylitis	0.000371	0.0017	CcSEcCtD
Nisoldipine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000371	0.0017	CcSEcCtD
Nisoldipine—Chills—Methotrexate—ankylosing spondylitis	0.000365	0.00167	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000362	0.00166	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000362	0.00166	CcSEcCtD
Nisoldipine—Arthralgia—Prednisone—ankylosing spondylitis	0.000361	0.00165	CcSEcCtD
Nisoldipine—Myalgia—Prednisone—ankylosing spondylitis	0.000361	0.00165	CcSEcCtD
Nisoldipine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000361	0.00165	CcSEcCtD
Nisoldipine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00036	0.00165	CcSEcCtD
Nisoldipine—Anxiety—Prednisone—ankylosing spondylitis	0.00036	0.00165	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—ankylosing spondylitis	0.00036	0.00165	CcSEcCtD
Nisoldipine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000359	0.00165	CcSEcCtD
Nisoldipine—Insomnia—Betamethasone—ankylosing spondylitis	0.000359	0.00165	CcSEcCtD
Nisoldipine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000357	0.00163	CcSEcCtD
Nisoldipine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000357	0.00163	CcSEcCtD
Nisoldipine—Discomfort—Prednisone—ankylosing spondylitis	0.000356	0.00163	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000351	0.00161	CcSEcCtD
Nisoldipine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00035	0.0016	CcSEcCtD
Nisoldipine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00035	0.0016	CcSEcCtD
Nisoldipine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000348	0.00159	CcSEcCtD
Nisoldipine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000347	0.00159	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000347	0.00159	CcSEcCtD
Nisoldipine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000346	0.00159	CcSEcCtD
Nisoldipine—Oedema—Prednisone—ankylosing spondylitis	0.000346	0.00158	CcSEcCtD
Nisoldipine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000345	0.00158	CcSEcCtD
Nisoldipine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000345	0.00158	CcSEcCtD
Nisoldipine—Shock—Prednisone—ankylosing spondylitis	0.00034	0.00156	CcSEcCtD
Nisoldipine—Tachycardia—Prednisone—ankylosing spondylitis	0.000338	0.00155	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000334	0.00153	CcSEcCtD
Nisoldipine—Anorexia—Prednisone—ankylosing spondylitis	0.00033	0.00151	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000329	0.00151	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—ankylosing spondylitis	0.000327	0.0015	CcSEcCtD
Nisoldipine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000327	0.0015	CcSEcCtD
Nisoldipine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000327	0.0015	CcSEcCtD
Nisoldipine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000322	0.00148	CcSEcCtD
Nisoldipine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000322	0.00147	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—ankylosing spondylitis	0.000319	0.00146	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—ankylosing spondylitis	0.000318	0.00146	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000317	0.00145	CcSEcCtD
Nisoldipine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000315	0.00145	CcSEcCtD
Nisoldipine—Urticaria—Betamethasone—ankylosing spondylitis	0.000315	0.00145	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000315	0.00144	CcSEcCtD
Nisoldipine—Dizziness—Prednisolone—ankylosing spondylitis	0.000315	0.00144	CcSEcCtD
Nisoldipine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000314	0.00144	CcSEcCtD
Nisoldipine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000314	0.00144	CcSEcCtD
Nisoldipine—Insomnia—Prednisone—ankylosing spondylitis	0.000313	0.00143	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000311	0.00142	CcSEcCtD
Nisoldipine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00031	0.00142	CcSEcCtD
Nisoldipine—Cough—Methotrexate—ankylosing spondylitis	0.000309	0.00142	CcSEcCtD
Nisoldipine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000309	0.00142	CcSEcCtD
Nisoldipine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000304	0.0014	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000302	0.00138	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—ankylosing spondylitis	0.000302	0.00138	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—ankylosing spondylitis	0.000302	0.00138	CcSEcCtD
Nisoldipine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000301	0.00138	CcSEcCtD
Nisoldipine—Rash—Prednisolone—ankylosing spondylitis	0.0003	0.00138	CcSEcCtD
Nisoldipine—Dermatitis—Prednisolone—ankylosing spondylitis	0.0003	0.00137	CcSEcCtD
Nisoldipine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000299	0.00137	CcSEcCtD
Nisoldipine—Headache—Prednisolone—ankylosing spondylitis	0.000298	0.00137	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—ankylosing spondylitis	0.000298	0.00137	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—ankylosing spondylitis	0.000291	0.00134	CcSEcCtD
Nisoldipine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000289	0.00133	CcSEcCtD
Nisoldipine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000289	0.00132	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000285	0.00131	CcSEcCtD
Nisoldipine—Nausea—Prednisolone—ankylosing spondylitis	0.000283	0.0013	CcSEcCtD
Nisoldipine—Pruritus—Betamethasone—ankylosing spondylitis	0.000281	0.00129	CcSEcCtD
Nisoldipine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000281	0.00129	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000279	0.00128	CcSEcCtD
Nisoldipine—Rash—Triamcinolone—ankylosing spondylitis	0.000276	0.00126	CcSEcCtD
Nisoldipine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000276	0.00126	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—ankylosing spondylitis	0.000276	0.00126	CcSEcCtD
Nisoldipine—Rash—Methylprednisolone—ankylosing spondylitis	0.000275	0.00126	CcSEcCtD
Nisoldipine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000275	0.00126	CcSEcCtD
Nisoldipine—Urticaria—Prednisone—ankylosing spondylitis	0.000275	0.00126	CcSEcCtD
Nisoldipine—Headache—Triamcinolone—ankylosing spondylitis	0.000274	0.00126	CcSEcCtD
Nisoldipine—Headache—Methylprednisolone—ankylosing spondylitis	0.000274	0.00125	CcSEcCtD
Nisoldipine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000273	0.00125	CcSEcCtD
Nisoldipine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000272	0.00125	CcSEcCtD
Nisoldipine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000272	0.00125	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—ankylosing spondylitis	0.00027	0.00124	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000263	0.00121	CcSEcCtD
Nisoldipine—Dizziness—Betamethasone—ankylosing spondylitis	0.000263	0.0012	CcSEcCtD
Nisoldipine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000263	0.0012	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—ankylosing spondylitis	0.000261	0.0012	CcSEcCtD
Nisoldipine—Nausea—Triamcinolone—ankylosing spondylitis	0.00026	0.00119	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00026	0.00119	CcSEcCtD
Nisoldipine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000259	0.00119	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000258	0.00118	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—ankylosing spondylitis	0.000257	0.00118	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000255	0.00117	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000254	0.00117	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000251	0.00115	CcSEcCtD
Nisoldipine—Rash—Betamethasone—ankylosing spondylitis	0.00025	0.00115	CcSEcCtD
Nisoldipine—Rash—Dexamethasone—ankylosing spondylitis	0.00025	0.00115	CcSEcCtD
Nisoldipine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00025	0.00115	CcSEcCtD
Nisoldipine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00025	0.00115	CcSEcCtD
Nisoldipine—Headache—Betamethasone—ankylosing spondylitis	0.000249	0.00114	CcSEcCtD
Nisoldipine—Headache—Dexamethasone—ankylosing spondylitis	0.000249	0.00114	CcSEcCtD
Nisoldipine—Pruritus—Prednisone—ankylosing spondylitis	0.000245	0.00112	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Nisoldipine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000237	0.00108	CcSEcCtD
Nisoldipine—Nausea—Betamethasone—ankylosing spondylitis	0.000236	0.00108	CcSEcCtD
Nisoldipine—Nausea—Dexamethasone—ankylosing spondylitis	0.000236	0.00108	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—ankylosing spondylitis	0.00023	0.00105	CcSEcCtD
Nisoldipine—Dizziness—Prednisone—ankylosing spondylitis	0.000229	0.00105	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000228	0.00105	CcSEcCtD
Nisoldipine—Rash—Prednisone—ankylosing spondylitis	0.000218	0.000999	CcSEcCtD
Nisoldipine—Dermatitis—Prednisone—ankylosing spondylitis	0.000218	0.000998	CcSEcCtD
Nisoldipine—Headache—Prednisone—ankylosing spondylitis	0.000217	0.000993	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000213	0.000976	CcSEcCtD
Nisoldipine—Nausea—Prednisone—ankylosing spondylitis	0.000205	0.000941	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—ankylosing spondylitis	0.000204	0.000937	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000198	0.000906	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—ankylosing spondylitis	0.000191	0.000876	CcSEcCtD
Nisoldipine—Rash—Methotrexate—ankylosing spondylitis	0.000182	0.000835	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000182	0.000834	CcSEcCtD
Nisoldipine—Headache—Methotrexate—ankylosing spondylitis	0.000181	0.00083	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—ankylosing spondylitis	0.000172	0.000787	CcSEcCtD
